Phreesia (PHR) Stock Price, News & Analysis

Company Overview

Phreesia, Inc. is a healthcare technology company that provides software and services designed to simplify and automate the patient intake process. Its platform helps healthcare organizations manage registration, consent forms, clinical questionnaires, insurance and demographic information, payments, and other administrative tasks through digital tools.

The company’s offerings are used by medical practices, health systems, and other healthcare organizations to improve patient engagement and support administrative and revenue-cycle workflows. Phreesia also provides solutions that help healthcare and life sciences organizations communicate with patients and deliver relevant education, services, and adherence support.

Founded in 2005, Phreesia is headquartered in New York. The company primarily serves healthcare organizations in the United States and Canada. Chaim Indig, a co-founder of Phreesia, serves as its chief executive officer.

Key Stats

• Today's Range: $10.09 to $10.49
• 50-Day Range: $9.67 to $12.64
• 52-Week Range: $7.77 to $24.25
• Volume: 504,068 shs
• Average Volume: 684,354 shs
• Market Capitalization: $643.98 million
• P/E Ratio: 61.03
• Dividend Yield: N/A
• Price Target: $14.00
• Consensus Rating: Hold

Phreesia Stock Analysis - MarketRank™

Phreesia scored higher than 77% of companies evaluated by MarketBeat, and ranked 155th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Phreesia has received a consensus rating of Hold. The company's average rating score is 2.37, and is based on no strong buy ratings, 8 buy ratings, 10 hold ratings, and 1 sell rating.

Upside Potential

Phreesia has a consensus price target of $14.00, representing about 34.9% upside from its current price of $10.38.

Amount of Analyst Coverage

Phreesia has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 124.24%

Earnings Growth

Earnings for Phreesia are expected to grow by 124.24% in the coming year, from $0.33 to $0.74 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Phreesia is 61.03, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 42.25.

Price to Earnings Ratio vs. Sector

The P/E ratio of Phreesia is 61.03, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 214.28.

Price to Book Value per Share Ratio

Phreesia has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.29% of the float of Phreesia has been sold short.

Short Interest Ratio / Days to Cover

Phreesia has a short interest ratio ("days to cover") of 4.17.

Change versus previous month

Short interest in Phreesia has recently increased by 6.42%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Phreesia does not currently pay a dividend.

Dividend Growth

Phreesia does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.54

News Sentiment

Phreesia has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Phreesia this week, compared to 8 articles on an average week.

Search Interest

Only 3 people have searched for PHR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $82,015.00 in company stock.

Percentage Held by Insiders

5.20% of the stock of Phreesia is held by insiders.

Percentage Held by Institutions

92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 9/02/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 12/14/2026
• Fiscal Year End: 1/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:PHR
• CIK: 1412408
• Web: www.phreesia.com
• Phone: (888) 654-7473
• Fax: 646-607-1776
• Employees: 1,789
• Year Founded: 2005

Price Target and Rating

• Average Price Target for Phreesia: $14.00
• High Price Target: $20.00
• Low Price Target: $10.00
• Potential Upside/Downside: +34.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.37
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.17
• Trailing P/E Ratio: 61.03
• Forward P/E Ratio: 31.44
• P/E Growth: N/A
• Net Income: $2.31 million
• Net Margins: 2.06%
• Pretax Margin: 0.54%
• Return on Equity: 5.22%
• Return on Assets: 3.02%

Debt

• Debt-to-Equity Ratio: 0.33
• Current Ratio: 1.76
• Quick Ratio: 1.76

Sales & Book Value

• Annual Sales: $480.59 million
• Price / Sales: 1.34
• Cash Flow: $0.77 per share
• Price / Cash Flow: 13.49
• Book Value: $5.59 per share
• Price / Book: 1.86

Miscellaneous

• Outstanding Shares: 62,070,000
• Free Float: 58,843,000
• Market Cap: $643.98 million
• Optionable: Optionable
• Beta: 0.84